IP Library Granted Patent US 7,534,885
Granted Patent B2
US 7,534,885 · App. 10/550,718 · Granted May 19, 2009

Process and intermediates for preparing emtricitabine

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,534,885
App. No.
10/550,718
Granted
May 19, 2009
Kind
B2
Abstract

A process is disclosed for the stereo-selective preparation of emtricitabine, which allows the desired product to be obtained in good yield and without the use of chromatographic techniques. The process for the production of emtricitabine of the formula (Ia) is characterized by the formation and isolation of intermediate compounds of formula (XIa) in salified form. Emtricitabine is a known antiviral drug.

Claims (13)

1. Process for preparing emtricitabine of formula (Ia)

comprising the salification reaction of an intermediate compound of formula (XIa)

dissolved in a suitable solvent, by treating the intermediate compound of formula (XIa) with an organic or mineral acid to give the corresponding salt, wherein the corresponding salt is in an isolable solid form.

2. The process of claim 1 , wherein the solvent is selected from the group consisting of alcohols, hydrocarbons, esters, ethers, chlorinated solvents, and mixtures thereof.

3. The process of claim 2 , wherein the solvent is selected from the group consisting of methanol, ethanol, isopropanol, toluene, ethyl acetate, propyl acetate, isopropyl acetate, butyl acetate, isobutyl acetate, tetrahydrofuran, dioxane, methylene chloride, and mixtures thereof.

4. The process of claim 1 , wherein said organic or mineral acid is selected from the group consisting of fumaric acid, maleic acid, lactic acid, salicylic acid, succinic acid, glycolic acid, tartaric acid, acetic acid, citric acid, formic acid, benzoic acid, malonic acid, oxalic acid, hydrochloric acid, hydrobromic acid, sulphuric acid, nitric acid, perchloric acid, phosphoric acid, p-toluenesulphonic acid, methanesulphonic acid, 2-naph-thalenesulphonic acid, benzenesulphonic acid, 4-chlorobenzenesulphonic acid, and mixtures thereof.

5. The process of claim 4 , wherein said organic or mineral acid is selected from the group consisting of oxalic acid, succinic acid, maleic acid, methanesulphonic acid, 4-chlorobenzene-sulphonic acid, hydrochloric acid, and mixtures thereof.

6. The process of claim 1 , further comprising isolating said corresponding salt by filtration.

7. Process for preparing the compound of formula (Ib)

comprising the salification reaction of an intermediate compound of formula (XId)

dissolved in a suitable solvent, by treating said intermediate compound of formula (XId) with organic or mineral acids to give the corresponding salt, which is insoluble in the said solvent, in readily isolable solid form.

8. The process of claim 2 , wherein the solvent is from the group consisting of methanol, isopropanol, ethyl acetate, and mixtures thereof.

9. The process of claim 4 , wherein said organic or mineral acid is oxalic acid.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2006
From: CLARIANT LIFE SCIENCE MOLECULES (ITALY) S.P.A.
To: ARCHIMICA S.R.L.
Reel/Frame 018061/0635 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2005
From: BERTOLINI, GIORGIO; DELEO, MAURIZIO; FRIGERIO, MARCO; LOSA, MASSIMO; VELATI, MAURIZIO
To: CLARIANT LIFE SCIENCE MOLECULES (ITALIA) S.P.A.
Reel/Frame 017834/0110 →